COVID-19 protection for elderly and immunocompromised individuals

Despite decreasing risks associated with COVID-19 due to vaccines and prior exposure, elderly and immunocompromised individuals remain at elevated risk. Updated vaccines and a new monoclonal antibody, Pemgarda, can provide increased protection for these groups. The CDC has updated guidelines for isolation and recommends multiple doses of the updated vaccines for higher-risk individuals.

Longest Covid Infection Duration in an Immunocompromised Patient

An elderly man in Amsterdam, who was immunocompromised, had a Covid infection for 613 days, during which the virus mutated around 50 times. This case highlights the potential dangers of prolonged infections in vulnerable patients.